Federation Des Caisses Desjardins Du Quebec Imv Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Aug 14, 2024
SELL
$0.22 - $3.64 $5,370 - $88,859
-24,412 Closed
0 $0
Q3 2022

Aug 14, 2024
SELL
$0.47 - $0.75 $2,083 - $3,324
-4,433 Reduced 15.37%
24,412 $12.6 Million
Q1 2022

Aug 14, 2024
BUY
$1.07 - $1.5 $30,864 - $43,267
28,845 New
28,845 $40.4 Million
Q4 2021

Aug 30, 2024
BUY
$1.22 - $1.78 $4,087 - $5,963
3,350 Added 13.14%
28,845 $35.1 Million
Q3 2021

Aug 30, 2024
BUY
$1.35 - $2.16 $1,350 - $2,160
1,000 Added 4.08%
25,495 $41.4 Million
Q2 2021

Aug 30, 2024
BUY
$2.12 - $3.24 $51,929 - $79,363
24,495 New
24,495 $52.1 Million
Q1 2021

Aug 30, 2024
BUY
$2.92 - $4.41 $37,119 - $56,059
12,712 Added 103.07%
25,045 $79.7 Million
Q4 2020

Aug 30, 2024
SELL
$2.9 - $4.4 $47,032 - $71,359
-16,218 Reduced 56.8%
12,333 $37.4 Million
Q3 2020

Aug 30, 2024
SELL
$2.87 - $5.95 $361,835 - $750,146
-126,075 Reduced 81.54%
28,551 $127 Million
Q2 2020

Aug 30, 2024
BUY
$1.52 - $3.63 $2,128 - $5,082
1,400 Added 0.91%
154,626 $471 Million
Q1 2020

Aug 30, 2024
SELL
$1.4 - $4.92 $7,429 - $26,110
-5,307 Reduced 3.35%
153,226 $253 Million
Q4 2019

Aug 30, 2024
BUY
$2.15 - $3.1 $78,896 - $113,757
36,696 Added 30.12%
158,533 $454 Million
Q3 2019

Aug 30, 2024
BUY
$2.25 - $3.82 $3,453 - $5,863
1,535 Added 1.28%
121,837 $297 Million
Q2 2019

Aug 30, 2024
BUY
$2.75 - $4.5 $22,000 - $36,000
8,000 Added 7.12%
120,302 $344 Million
Q1 2019

Aug 30, 2024
BUY
$3.6 - $5.84 $168,850 - $273,913
46,903 Added 71.72%
112,302 $445 Million
Q4 2018

Aug 30, 2024
BUY
$4.93 - $6.34 $322,417 - $414,629
65,399 New
65,399 $331 Million
Q3 2018

Aug 30, 2024
BUY
$4.65 - $5.94 $137,351 - $175,455
29,538 Added 125.03%
53,162 $308 Million
Q2 2018

Aug 30, 2024
BUY
$4.42 - $7.13 $104,418 - $168,439
23,624 New
23,624 $120 Million

About IMV Inc.

IMV Quotes by TradingView
  • Ticker IMV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,452,200
  • Description
  • IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...
More about IMV
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email